Literature DB >> 26933311

Pulmonary cryptosporidiosis in an immunocompetent host treated successfully with nitazoxanide.

Harish Kumar1, Veer Bahadur Singh1, Babu Lal Meena1, Jatin Agrawal1, Sanjay Beniwal1, Taruna Swami2.   

Abstract

Cryptosporidium parvum is an intracellular spore-forming protozoa which predominantly causes intestinal diseases. It causes severe and life-threatening diarrheal diseases in immunocompromised hosts and usually self-limiting disease in immunocompetent hosts. Extra-intestinal manifestations of cryptosporidium infection are very rare. Herein, we report a case of pulmonary cryptosporidiosis in a 35-yrs-old immunocompetent host, who presented with fever, cough and breathlessness which was soon followed by diarrhea and vomiting, had lung consolidation, and treated successfully with nitazoxanide.

Entities:  

Keywords:  Cryptosporidium; HIV; immunocompetent; nitazoxanide; oocysts

Year:  2016        PMID: 26933311      PMCID: PMC4748669          DOI: 10.4103/0970-2113.173085

Source DB:  PubMed          Journal:  Lung India        ISSN: 0970-2113


INTRODUCTION

Cryptosporidium parvum is an intracellular spore forming protozoan. It primarily infects epithelial cells of small intestinal and responsible for major cause of diarrheal disease in both immunocompetent as well as immunocompromised individuals. The cryptosporidium diarrheal disease in immunocompetent individual is usually of short duration and self limiting. It causes severe and life-threatening diarrheal disease in immunocompromised individuals mainly in those suffering from HIV/AIDS.[1] Extra-intestinal cryptosporidium disease has been reported in patient with AIDS.[23] Acalculous cholecystitis or papillary stenosis, pancreatitis, lung, and middle ear infection have been found in the literature.[4] Pulmonary disease is a rare extra-intestinal manifestation of cryptosporidium infection and its presence in an immunocompetent host makes it further rarer. Herein, we report a case of pulmonary cryptosporidiosis in an immunocompetent host, which was soon followed by intestinal disease symptoms, treated successfully with nitazoxanide.

CASE REPORT

A 35-year-old non-alcoholic rural male presented with 5-days history of intermittent fever with chills, cough with expectoration and breathlessness. After admission patient had history of four episodes of profuse watery diarrhea associated with nausea and one episode of watery vomiting. There was no history of hemoptysis, blood in stool, and weight loss. He had a history of farming before hospitalization. He was not suffering from any chronic illness and had no addiction to any drugs. On examination, the patient was febrile, conscious, cooperative, and well-oriented. His blood pressure was 110/80 mm of Hg, pulse rate 106 beats/min regular, respiratory rate 22 breaths/min, temperature 38.2°C by axilla and oxygen saturation on room air was 98%. On chest auscultation crepitations were found on right lower zone. Other systemic examinations were normal. Routine blood investigations were sent before he was put on intravenous fluid and antibiotics. Laboratory investigations revealed hemoglobin of 13.8 g/dL, total leukocyte count 13,000/mm3 with 80% neutrophils, 17% lymphocytes, 2% monocytes and 165000/mm3 platelets. The blood sugar was 94 mg/dL, blood urea 35 mg/dL, S. creatinine 1.0 mg/dL, AST 25 IU/L, ALT 20 IU/L, S.LDH 230 IU/L and total protein was 6.9 g/dL with 4.3 g/dL albumin. Serum immunoglobulin's IgG, IgA, IgM and CD4-T cell count were within normal range. He was tested non-reactive for HIV 1 and 2 and negative for malaria parasite test. Mantoux skin test was also negative. Sputum samples were examined for the presence of bacteria, fungus, mycobacterium and nocardia with Grams staining, Ziehl-Neelsen (ZN) staining, and modified acid-fast stains (kinyon stain). Sputum culture was done for these organisms according to their specific culture media. Microscopic examination of sputum smear stained with ZN and modified ZN staining showed of 4-6 μ, circular and acid-fast structures [Figure 1]. These structures were identified as oocysts of cryptosporidium parvum. Modified ZN staining of stool smear also showed a lot of cryptosporidium oocysts [Figure 2]. The presence of acid-fast structures of cryptosporidium oocysts were confirmed on repeat modified ZN staining of sputum and stool sample after 2 days. No pathogenic bacteria including mycobacterium tuberculosis were grown in culture. Blood and urine culture were sterile for any pathogenic bacteria. Chest X-ray PA view revealed right lower zone consolidation [Figure 3b]. After conformation of cryptosporidium infection, he was treated with nitazoxanide for 3 days. He became asymptomatic with complete resolution of opacities on chest X-ray after treatment [Figure 3a] Oocysts were no longer detected in stool and sputum.
Figure 1

Cryptosporidium in sputum on modified ZN staining ×100

Figure 2

Cryptosporidium in stool on modified ZN staining

Figure 3

(a) Chest X-ray showing consolidation patch on right lower zone before treatment (b) Complete resolution of opacities on chest X-ray after treatment with nitazoxanide

Cryptosporidium in sputum on modified ZN staining ×100 Cryptosporidium in stool on modified ZN staining (a) Chest X-ray showing consolidation patch on right lower zone before treatment (b) Complete resolution of opacities on chest X-ray after treatment with nitazoxanide

DISCUSSION

Transmission of Cryptosporidium occurs through the fecal/oral route after the ingestion of occysts (Infective stage of C. parvum). Ingestion can occur via person-to-person, zoonotic, waterborne, food-borne and airborne contact.[5] Cryptosporidium usually infect small gastrointestinal tract epithelium, multiplies within the macrophages and causes diarrheal diseases. Theses spores can migrate to the whole gastrointestinal tract, respiratory epithelium, and biliary tract. Severity of diseases depends on the immunity of the patients. In immunocompetent individuals rapid clearance of the organism is responsible for asymptomatic and self-limiting disease.[6] Immunocompromised individuals are prone for severe and fatal disease. Extra-intestinal manifestations are also common in these individuals. Most common extra-intestinal manifestations are bile tract infections which can lead to acalculous cholecystitis or papillary stenosis and pancreatitis. Lung infections and middle ear infections were also found.[47] A case of pulmonary cryptosporidiosis in a HIV-negative immunocompetent child who was receiving corticosteroids has been reported.[8] The pulmonary cryptosporidiosis rarely reported and commonly associated with diarrhea. The pathogenesis of lung disease is not fully understood.[9] The lung diseases can occur due to the inhalation of spores or migration of oocysts from gastrointestinal tract through circulating phagocytes. The common presenting symptoms of pulmonary cryptosporidiosis are non-specific and typically include chronic cough, fever, and dyspnea. Radiological changes may or may not occur.[910] Our patient presented because of fever, cough and breathlessness and had diarrhea after 5 days. He was a farmer. Thus we assumed that inhalation of spore or ingestion of contaminated food or water might be the route of transmission of cryptosporidium. There is a possibility of hematogenous spread of transmission of oocysts through circulating phagocytes to the gastrointestinal tract, other than ingestion of contaminated food or water for intestinal symptoms. He was treated successfully with nitazoxanide and loperamide and he became asymptomatic with normal chest X-ray and no evidence of oocysts on the sputum and stool staining after 5 days of treatment. Proceeding of respiratory symptoms to diarrhea after cryptosporidium infection in an immunocompetent host along with lung consolidation and good response to nitazoxanide makes this case rarer.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  9 in total

Review 1.  Cryptosporidiosis.

Authors:  Xian-Ming Chen; Janet S Keithly; Carlos V Paya; Nicholas F LaRusso
Journal:  N Engl J Med       Date:  2002-05-30       Impact factor: 91.245

Review 2.  Cryptosporidium and cryptosporidiosis.

Authors:  R C A Thompson; M E Olson; G Zhu; S Enomoto; Mitchell S Abrahamsen; N S Hijjawi
Journal:  Adv Parasitol       Date:  2005       Impact factor: 3.870

Review 3.  Respiratory cryptosporidiosis: case series and review of the literature.

Authors:  A Clavel; A C Arnal; E C Sánchez; J Cuesta; S Letona; J A Amiguet; F J Castillo; M Varea; R Gómez-Lus
Journal:  Infection       Date:  1996 Sep-Oct       Impact factor: 3.553

4.  Microbiological findings about pulmonary cryptosporidiosis in two AIDS patients.

Authors:  C Dupont; M E Bougnoux; L Turner; E Rouveix; M Dorra
Journal:  J Clin Microbiol       Date:  1996-01       Impact factor: 5.948

Review 5.  New insights into human cryptosporidiosis.

Authors:  D P Clark
Journal:  Clin Microbiol Rev       Date:  1999-10       Impact factor: 26.132

6.  [Pulmonary cryptosporidiosis in AIDS patients].

Authors:  M Corti; M F Villafañe; E Muzzio; J Bava; J C Abuín; O J Palmieri
Journal:  Rev Argent Microbiol       Date:  2008 Apr-Jun       Impact factor: 1.852

7.  Cryptosporidium infection in patients with primary immunodeficiencies.

Authors:  Beata Wolska-Kusnierz; Anna Bajer; Simone Caccio; Edyta Heropolitanska-Pliszka; Ewa Bernatowska; Piotr Socha; Jacques van Dongen; Malgorzata Bednarska; Anna Paziewska; Edward Sinski
Journal:  J Pediatr Gastroenterol Nutr       Date:  2007-10       Impact factor: 2.839

8.  Pulmonary cryptosporidiosis in HIV negative, immunocompromised host.

Authors:  S N Shrikhande; C A Chande; V R Shegokar; R M Powar
Journal:  Indian J Pathol Microbiol       Date:  2009 Apr-Jun       Impact factor: 0.740

9.  Cryptosporidium species and subtypes and clinical manifestations in children, Peru.

Authors:  Vitaliano A Cama; Caryn Bern; Jacqueline Roberts; Lilia Cabrera; Charles R Sterling; Ynes Ortega; Robert H Gilman; Lihua Xiao
Journal:  Emerg Infect Dis       Date:  2008-10       Impact factor: 6.883

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.